Eliminating silos in multi-omics: integrated protein and nucleic acid analysis in one harmonized workflow on Codetta Bio’s Concerto system
Join us to discover how the Concerto system from Codetta Bio is redefining multi-omics by enabling simultaneous, high-sensitivity quantification of proteins and nucleic acids in a single, harmonized workflow. Built on microbead-based target capture and a powerful combination of digital PCR, real-time PCR, and immunoPCR, Concerto leverages proprietary noise-canceling chemistry, advanced optics, and precision thermal control to generate up to six million parallel reactions per run—delivering sub-pg/mL sensitivity and up to eight logs of dynamic range without serial dilutions.
Designed for ease of use, the platform integrates encoded bead sets and automated chip loading to streamline multiplex biomarker detection from liquid biopsies. By consolidating workflows traditionally spread across multiple instruments, Concerto reduces complexity, lowers operational costs, and unlocks deeper, more actionable multi-omic insights for precision medicine research and diagnostics.
Speaker Biographies
William Henley co-founded Codetta Bio with Prof. J. Michael Ramsey after leading the invention and development of the technology in the Ramsey lab at The University of North Carolina.
Their goal was to make this advanced technology accessible to life science researchers, reflecting their strong commitment to enabling scientific innovation and research. William is currently the VP of Research and Innovation at Codetta where he leads the platform development team.
Related Events
For more on this topic, you may be interested in our upcoming Biomarkers, CDx & Precision Medicine. 2026Catch up on other Precision Medicine resources on our Resources page
